These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 5997895

  • 1. [Treatment of ascites in hepatic cirrhosis].
    Arroyo JL, Bueno J, Rivero A, Lucas I, Ortiz de Landazuri E.
    Rev Esp Enferm Apar Dig; 1966 Nov; 25(9):1021-46. PubMed ID: 5997895
    [No Abstract] [Full Text] [Related]

  • 2. Combinations of diuretics in the treatment of edema.
    Leiter L.
    Am Heart J; 1970 Sep; 80(3):422-6. PubMed ID: 4915356
    [No Abstract] [Full Text] [Related]

  • 3. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H, Perret M, Etaix JP.
    J Med Lyon; 1967 Feb 05; 48(114):173-83. PubMed ID: 5600100
    [No Abstract] [Full Text] [Related]

  • 4. Amiloride. A potassium-sparing natriuretic agent.
    Bull MB, Laragh JH.
    Circulation; 1968 Jan 05; 37(1):45-53. PubMed ID: 5634728
    [No Abstract] [Full Text] [Related]

  • 5. [The behavior of uricemia during treatment with spironolactone and with other diuretics].
    Bufalari A, Meloni G.
    Minerva Med; 1967 Nov 07; 58(89):3815-22. PubMed ID: 6074933
    [No Abstract] [Full Text] [Related]

  • 6. [Triamterene in diuretic therapy of cirrhogenic ascites. Modifications of water-saline metabolism induced by its administration alone and in combination with fluprednisolone, methopyrone, mercaptomerine and benzothiazides].
    Ventura E, Loiodice L, Marani L.
    Minerva Med; 1963 Oct 10; 54(81 Suppl):3024-7. PubMed ID: 5877334
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
    Castagnolo B, De Colibus V, Napolitano L, Aliperta A, Caldarelli G, Abignente F.
    Clin Ter; 1977 Dec 31; 83(6):625-9. PubMed ID: 343976
    [No Abstract] [Full Text] [Related]

  • 8. [Value of the association of a certain dose of spironolactone with a sulfamide diuretic in the treatment of ascitic cirrhosis].
    Brette R, Pasquier J, Mestrallet G, Olivier L.
    Sem Ther; 1964 Jan 31; 40(1):34-40. PubMed ID: 5878908
    [No Abstract] [Full Text] [Related]

  • 9. [Conservative treatment of ascites in patients with cirrhosis of the liver].
    Hartleb J, Mazur W.
    Wiad Lek; 1964 Jan 31; 42(16-18):1000-5. PubMed ID: 2640068
    [No Abstract] [Full Text] [Related]

  • 10. [Rational use of diuretics in hepatic cirrhosis].
    Vagge R, Cavatorta F, Queirolo C.
    G Clin Med; 1983 Jan 31; 64(3-4):116-23. PubMed ID: 6884638
    [No Abstract] [Full Text] [Related]

  • 11. Diuretics.
    Earley LE.
    N Engl J Med; 1967 Apr 27; 276(17):966-8. PubMed ID: 6025657
    [No Abstract] [Full Text] [Related]

  • 12. Newer diuretics in the treatment of cardiac or hepatic disease in elderly patients.
    Steigmann F, Oz R, Dubin A.
    J Am Geriatr Soc; 1966 Dec 27; 14(12):1232-8. PubMed ID: 5954532
    [No Abstract] [Full Text] [Related]

  • 13. Hyperkalemic intermittent paralysis associated with spironolactone in a patient with cardiac cirrhosis.
    Radó JP, Marosi J, Takó J, Dévényi I.
    Am Heart J; 1968 Sep 27; 76(3):393-8. PubMed ID: 4951338
    [No Abstract] [Full Text] [Related]

  • 14. SPIRONOLACTONE IN REFRACTORY ASCITES IN HEPATIC CIRRHOSIS.
    SHAH MJ, KHOKHANI RC, VAIDYA AB, SHETH UK.
    J Assoc Physicians India; 1963 Oct 27; 11():837-42. PubMed ID: 14071784
    [No Abstract] [Full Text] [Related]

  • 15. Studies on furosemide: an effective oral saludiuretic for bilharzial ascites.
    Shafei AZ, Habib YA, el-Khangry HA, Abou-Khair SA, Abaza HH, Nibal AH.
    J Trop Med Hyg; 1967 Dec 27; 70(12):286-92. PubMed ID: 6061451
    [No Abstract] [Full Text] [Related]

  • 16. [Modern diuretics in the treatment of ascites caused by hepatic cirrhosis].
    Buligescu L, Candiori R.
    Med Interna (Bucur); 1970 May 27; 22(5):573-92. PubMed ID: 5426383
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S, Bellati G, Ideo G.
    Minerva Dietol Gastroenterol; 1984 May 27; 30(3):255-61. PubMed ID: 6504374
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of resistant ascites in cirrhotic patients].
    Aronoff A, Nayarai I.
    Union Med Can; 1974 Dec 27; 103(12):2081-9. PubMed ID: 4466021
    [No Abstract] [Full Text] [Related]

  • 19. Spironolactone and frusemide in cirrhosis with ascites.
    Sadikali F.
    Br J Clin Pract; 1973 Jun 27; 27(6):222-4. PubMed ID: 4582147
    [No Abstract] [Full Text] [Related]

  • 20. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A, Codden T, Henry JP, Van Cauter J, Meunier JC, Ligny G.
    Gastroenterol Clin Biol; 2001 Mar 27; 25(3):268-72. PubMed ID: 11395674
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.